Food News and Research

RSS

Patented chemical derived from sugar may be an alternative for BPA

Michael Jaffe, a professor of biomedical engineering at NJIT, has received a patent for a chemical derived from sugar. This new material is a derivative of isosorbide and may be able to replace bisphenol A (BPA) in a number of consumer products, including the lining of tin cans.

25 Feb 2010

FDA sets new PDUFA action date for exenatide once weekly NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).

25 Feb 2010

Biovail reports 33% increase in total revenues for fourth-quarter 2009

Biovail Corporation today announced financial results for the three-month and 12-month periods ending December 31, 2009.

25 Feb 2010

CFIA approves export of Neovasc's processed pericardial tissue products to Europe

Neovasc Inc., today announced that it has received Canadian Food Inspection Agency (CFIA) approval to export its processed pericardial tissue products to Europe as an "intermediate product" under the requirements of Annex I of EC Regulation # 2007/2006. This approval allows European customers to import Neovasc's porcine and bovine pericardial tissue materials for use in the manufacture of their own medical devices.

25 Feb 2010

Adolor announces $14.6M net product sales of ENTEREG for year ended December 31, 2009

Adolor Corporation today reported a net loss of $47.9 million, or $(1.03) per basic and diluted share, for the year ended December 31, 2009, compared to a net loss of $30.1 million, or $(0.65) per basic and diluted share, for the year ended December 31, 2008.

25 Feb 2010

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.

25 Feb 2010

Taxing unhealthy foods may promote healthy food choices

Recently, the Obama administration called for a total ban on candy and soda in the nation's schools. States are beginning to impose "sin taxes" on fat and sugar to dissuade people from eating junk food. Pricing strategies may well be a key to changing behavior, but others favor subsidies over punitive taxes, as a way to encourage people to eat fruits and vegetables and whole grains.

25 Feb 2010

New book details how Greenway Medical Technologies' PrimeResearch integrates with PrimeSuite

Paper Kills 2.0: How Health IT Can Help Save Your Life and Your Money, is due out today by the Washington, D.C.-based Center for Health Transformation.

25 Feb 2010

YoNaturals' healthy nutrition agenda could help combat childhood obesity

Mark Trotter is the charismatic CEO of YoNaturals, the leader in natural and organic snack food vending. And he's led his feisty San Diego company on its own inspired mission to improve the diets of our nation's school age children.

25 Feb 2010

Soy products meet nutritional needs of people with lactose intolerance

Today, nutrition experts and physicians who participated in the NIH Consensus Development Conference on Lactose Intolerance and Health released an important report that concluded individuals who ingest inadequate amounts of calcium and vitamin D because of real or perceived lactose intolerance need dietary advice to ensure appropriate intake of missing nutrients.

25 Feb 2010

Food-attributed illness poses a major problem for food manufacturers and suppliers

Over the past several years Americans have seen numerous food recalls related to our nation’s food supply. Spinach, peanut butter and even pet food are just some of the food items that have been subject to massive recalls.

25 Feb 2010

A surgical cure for diabetic and obese patients

Dr. Francesco Rubino, chief of gastrointestinal metabolic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is now enrolling overweight and mildly obese patients -- those with a body mass index (BMI) of 28 to 35 -- in a study of gastric bypass surgery aimed at reversing Type 2 diabetes.

25 Feb 2010

Recycling medical equipment saves money and reduces waste

Wider adoption of the practice of recycling medical equipment — including laparoscopic ports and durable cutting tools typically tossed out after a single use — could save hospitals hundreds of millions of dollars annually and curb trash at medical centers, the second-largest waste producers in the United States after the food industry.

25 Feb 2010

Rapamycin may hold promise for Alzheimer's disease

Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer's disease.

25 Feb 2010

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.

25 Feb 2010

EpiCept provides business update and fourth-quarter financial highlights

EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company’s key product candidates.

25 Feb 2010

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

The U.S. Food and Drug Administration and the National Institutes of Health today unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.

25 Feb 2010

TWC, TSC announce the grand opening of new facilities at St. John’s Medical Plaza in Santa Monica

Tower Wound Care Center of Santa Monica and Tower Surgical Center are pleased to announce the grand opening of its new state-of-the-art facilities at St. John’s Medical Plaza in Santa Monica, California.

25 Feb 2010

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Virginia Life Science Investments, LLC and other investors have completed a recapitalization and management restructuring of Cupron, Inc., a Delaware corporation established in 2001, with principal offices in Modi’in, Israel. The transaction provides significant new capital to support the continued growth and development of Cupron Inc.; as well as the formation and initial capitalization of an independent new entity, Cupron Medical Inc., a Delaware corporation with principal offices in Richmond, VA.

25 Feb 2010

Study examines associations of different fats and subtypes of ischemic stroke in post-menopausal women

Post-menopausal women who reported consuming the most daily dietary fat had a 40 percent higher incidence of clot-caused strokes compared to women who ate the least amount, according to research presented at the American Stroke Association's International Stroke Conference 2010.

25 Feb 2010

Food News and Research

Patented chemical derived from sugar may be an alternative for BPA

FDA sets new PDUFA action date for exenatide once weekly NDA

Biovail reports 33% increase in total revenues for fourth-quarter 2009

CFIA approves export of Neovasc's processed pericardial tissue products to Europe

Adolor announces $14.6M net product sales of ENTEREG for year ended December 31, 2009

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

Taxing unhealthy foods may promote healthy food choices

New book details how Greenway Medical Technologies' PrimeResearch integrates with PrimeSuite

YoNaturals' healthy nutrition agenda could help combat childhood obesity

Soy products meet nutritional needs of people with lactose intolerance

Food-attributed illness poses a major problem for food manufacturers and suppliers

A surgical cure for diabetic and obese patients

Recycling medical equipment saves money and reduces waste

Rapamycin may hold promise for Alzheimer's disease

Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS

EpiCept provides business update and fourth-quarter financial highlights

FDA, NIH initiative: From scientific breakthrough to the availability of new medical therapies for patients

TWC, TSC announce the grand opening of new facilities at St. John’s Medical Plaza in Santa Monica

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Study examines associations of different fats and subtypes of ischemic stroke in post-menopausal women

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News